Skip to the main content.

Newsroom

KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility

EXPANDS US-BASED MAMMALIAN CELL CULTURE OPERATIONS

Read More

Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

KBI TO PRODUCE MATERIAL FOR USE IN FUTURE EXPECTED PHASE 2 CLINICAL TRIAL OF ORAGENICS’ INTRANASAL VACCINE CANDIDATE

Read More

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

KBI BIOPHARMA COMPLETES EUROFINS DISCOVERX PRODUCTS SPECIALIZED BIOASSAY CERTIFICATION PROGRAM Companies will work together on critical components...

Read More

Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

Read More

Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

SELEXIS AND KBI BIOPHARMA ENTER INTO AGREEMENTS WITH IMMATICS FOR INTEGRATED APPROACH TO ADVANCE IMMATICS TCR BISPECIFIC PROGRAM TOWARDS IND

Read More

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

KBI BIOPHARMA ENTERS COMMERCIAL MANUFACTURING AGREEMENT WITH AM-PHARMA TO PREPARE FOR THE COMMERCIAL LAUNCH OF LEAD PROGRAM IN ACUTE KIDNEY DISEASE

Read More

Durham Tech and KBI BioPharma Partner to Boost Diversity and Create Life Sciences Job Opportunities for North Carolina Students and Veterans

DURHAM TECH AND KBI BIOPHARMA PARTNER TO BOOST DIVERSITY AND CREATE LIFE SCIENCES JOB OPPORTUNITIES FOR NORTH CAROLINA STUDENTS AND VETERANS

Read More

KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina

KBI BIOPHARMA EXPANDS US OPERATIONS WITH NEW $150 MILLION COMMERCIAL MANUFACTURING FACILITY BASED IN RTP, NORTH CAROLINA

Read More

JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities For Selexis And KBI Biopharma In Geneva, Switzerland

JSR LIFE SCIENCES EXPANDS ITS EUROPEAN GENE-TO-GMP BIOLOGICS MANUFACTURING FACILITIES FOR SELEXIS AND KBI BIOPHARMA IN GENEVA, SWITZERLAND

Read More

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.